Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

About the Emerging Infectious Diseases journal

General Information

Emerging Infectious Diseases is an open access journal published monthly by the Centers for Disease Control and Prevention (CDC). The journal is published online and also has a limited print run on acid free paper that meets the requirements of ANSI/NISO Z39.48-1984 (Permanence of Paper). Publication in EID enables compliance with the NIH Public Access Policy.

Emerging Infectious Diseases follows the International Committee of Medical Journal Editors recommendations for the conduct, reporting, editing, and publishing of scholarly work in medical journals. The journal’s peer review process allows for critical assessment of submitted manuscripts by experts who are usually not part of its editorial staff. As an independent publication, the journal’s peer-review process operates independently from CDC’s clearance processes. 

The conclusions, findings, and opinions expressed by authors contributing to Emerging Infectious Diseases do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.

Contact us for additional information.


EMERGING INFECTIOUS DISEASES ® is a registered service mark of the US Department of Health and Human Services. Its Registration Number 4,972,553 is issued by the United States Patent & Trademark Office (USPTO).

2016 Impact Factor (Journal Citation Reports, 2015)

EID’s 2016 impact factor is 6.99, first among open-access infectious disease journals and 4th among the 82 tracked infectious disease journals. EID’s high impact factor indicates that articles published in the journal during the last 2 years have been cited an average of nearly 7 times during the past year.

2016 Google Scholar h-Index

Indexing and Full Text Content

Emerging Infectious Diseases is indexed in Index Medicus/Medline, Current Contents, Excerpta Medica, Literature, Arts, and Medicine Database. Full text content is available in PubMed Central, CrossRef, and LinkOut.

Full abstracts for all of EID’s Ahead-of-Print articles and online reports are now accessible via, in addition to our current and past publications. Each article contains a digital object identifier (DOI) link to the original, complete article on the EID website.

Submissions and Acceptance

  • Emerging Infectious Diseases receives more than 2,000 manuscripts per year (most unsolicited, some invited) from authors around the world.
  • Approximately 25% of submitted articles are accepted.


  • 4,500 subscribers to print version
  • 88,927 subscribers to table of contents
  • The journal site receives millions of hits annually (CDC Web Statistics)
  • 151,221 unique subscribers to any of EID’s GovDelivery emails